CannTrust (OTCMKTS:CNTTF) is scheduled to post its quarterly earnings results before the market opens on Thursday, March 28th.

CannTrust stock opened at $9.63 on Tuesday. The stock has a market cap of $1.02 billion, a PE ratio of 137.57 and a beta of 4.52. CannTrust has a one year low of $4.35 and a one year high of $11.97.

Several equities analysts have recently commented on the stock. Roth Capital restated a “buy” rating on shares of CannTrust in a research report on Thursday, December 20th. Jefferies Financial Group began coverage on shares of CannTrust in a research report on Monday, February 25th. They issued a “buy” rating for the company.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at

CannTrust Company Profile

CannTrust Holdings Inc produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital.

Read More: Fundamental Analysis and Choosing Stocks

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with's FREE daily email newsletter.